Biotechnology
The Biotechnology industry has a total of 604 stocks, with a combined market cap of $1.11 trillion and total revenue of $105.21 billion.
Market Cap
1.11T
Revenue
105.21B
Profits
-42.17B
PE Ratio
n/a
Profit Margin
-40.09%
Dividend Yield
0.04%
604 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | VRTX | Vertex Pharmaceuticals Incorporated | 114.58B | 0.94% | 712,740 | 11.72B |
| 2 | REGN | Regeneron Pharmaceuticals, Inc. | 77.98B | 1.51% | 490,305 | 14.25B |
| 3 | ALNY | Alnylam Pharmaceuticals, Inc. | 53.50B | 2.25% | 530,226 | 3.21B |
| 4 | ARGX | argenx SE | 52.32B | 1.41% | 130,396 | 3.68B |
| 5 | INSM | Insmed Incorporated | 37.51B | 5.59% | 1,928,310 | 447.02M |
| 6 | ONC | BeOne Medicines AG | 34.97B | 2.93% | 63,730 | 4.97B |
| 7 | RPRX | Royalty Pharma plc | 22.31B | 0.57% | 947,266 | 2.35B |
| 8 | BNTX | BioNTech SE | 22.28B | 1.29% | 957,923 | 3.70B |
| 9 | INCY | Incyte Corporation | 19.79B | 3.59% | 878,729 | 4.81B |
| 10 | GMAB | Genmab A/S | 19.39B | 2.98% | 1,932,708 | 3.85B |
| 11 | ROIV | Roivant Sciences Ltd. | 15.59B | 2.89% | 2,230,665 | 20.33M |
| 12 | RVMD | Revolution Medicines, Inc. | 14.92B | 1.61% | 526,044 | - |
| 13 | BBIO | BridgeBio Pharma, Inc. | 14.53B | 1.67% | 774,013 | 353.78M |
| 14 | SMMT | Summit Therapeutics Inc. | 13.56B | 3.17% | 765,636 | - |
| 15 | MDGL | Madrigal Pharmaceuticals, Inc. | 13.36B | 8.09% | 377,915 | 740.64M |
| 16 | MRNA | Moderna, Inc. | 13.29B | 9.89% | 7,017,313 | 2.23B |
| 17 | IONS | Ionis Pharmaceuticals, Inc. | 12.87B | 2.38% | 572,111 | 966.96M |
| 18 | ASND | Ascendis Pharma A/S | 12.25B | 0.36% | 360,036 | 758.59M |
| 19 | BMRN | BioMarin Pharmaceutical Inc. | 11.84B | 18.65% | 8,792,578 | 3.09B |
| 20 | EXEL | Exelixis, Inc. | 11.70B | 2.11% | 740,495 | 2.29B |
| 21 | RNA | Avidity Biosciences, Inc. | 10.86B | -0.10% | 680,180 | 20.87M |
| 22 | JAZZ | Jazz Pharmaceuticals plc | 10.18B | 0.96% | 267,801 | 4.16B |
| 23 | ARWR | Arrowhead Pharmaceuticals, Inc. | 9.26B | 2.54% | 642,199 | 829.45M |
| 24 | TECH | Bio-Techne Corporation | 9.07B | 1.98% | 615,379 | 1.22B |
| 25 | CORT | Corcept Therapeutics Incorporated | 8.92B | 4.05% | 317,921 | 741.17M |
| 26 | ABVX | ABIVAX Société Anonyme | 8.92B | 3.06% | 839,165 | 6.23M |
| 27 | NUVL | Nuvalent, Inc. | 8.05B | 2.28% | 203,286 | - |
| 28 | CAI | Caris Life Sciences, Inc. | 7.94B | 1.01% | 827,958 | 649.06M |
| 29 | HALO | Halozyme Therapeutics, Inc. | 7.86B | 2.69% | 726,156 | 1.24B |
| 30 | AXSM | Axsome Therapeutics, Inc. | 7.71B | 4.05% | 385,099 | 561.26M |
| 31 | CYTK | Cytokinetics, Incorporated | 7.67B | 0.92% | 561,788 | 87.21M |
| 32 | RYTM | Rhythm Pharmaceuticals, Inc. | 7.54B | 1.14% | 202,681 | 174.33M |
| 33 | MRUS | Merus N.V. | 7.34B | 0.03% | 311,198 | 56.61M |
| 34 | KRYS | Krystal Biotech, Inc. | 7.04B | 4.06% | 114,331 | 373.16M |
| 35 | CDTX | Cidara Therapeutics, Inc. | 6.94B | -0.08% | 176,308 | 302.00K |
| 36 | PRAX | Praxis Precision Medicines, Inc. | 6.86B | 1.82% | 185,998 | 7.46M |
| 37 | KYMR | Kymera Therapeutics, Inc. | 6.60B | 3.60% | 385,476 | 43.74M |
| 38 | PTCT | PTC Therapeutics, Inc. | 6.25B | 4.32% | 431,230 | 1.78B |
| 39 | COGT | Cogent Biosciences, Inc. | 5.95B | 3.14% | 900,222 | - |
| 40 | PCVX | Vaxcyte, Inc. | 5.89B | 3.02% | 667,205 | - |
| 41 | BLTE | Belite Bio, Inc | 5.79B | -0.14% | 233,782 | - |
| 42 | IMVT | Immunovant, Inc. | 5.46B | 2.83% | 792,239 | - |
| 43 | PTGX | Protagonist Therapeutics, Inc. | 5.38B | 0.33% | 467,285 | 209.22M |
| 44 | APGE | Apogee Therapeutics, Inc. | 5.38B | 3.06% | 343,640 | - |
| 45 | CRSP | CRISPR Therapeutics AG | 5.35B | 2.46% | 480,062 | 38.34M |
| 46 | CELC | Celcuity Inc. | 4.79B | 4.34% | 190,097 | - |
| 47 | ADMA | ADMA Biologics, Inc. | 4.67B | 4.31% | 786,439 | 488.56M |
| 48 | ACAD | ACADIA Pharmaceuticals Inc. | 4.63B | 2.97% | 498,223 | 1.05B |
| 49 | TGTX | TG Therapeutics, Inc. | 4.56B | 4.11% | 920,607 | 531.90M |
| 50 | CRNX | Crinetics Pharmaceuticals, Inc. | 4.53B | 5.69% | 329,020 | 1.54M |
| 51 | SRRK | Scholar Rock Holding Corporation | 4.52B | 3.21% | 312,355 | - |
| 52 | FOLD | Amicus Therapeutics, Inc. | 4.38B | 30.35% | 136,776,520 | 598.70M |
| 53 | TERN | Terns Pharmaceuticals, Inc. | 4.24B | 0.20% | 1,174,233 | - |
| 54 | GPCR | Structure Therapeutics Inc. | 4.07B | 7.30% | 925,741 | - |
| 55 | LEGN | Legend Biotech Corporation | 4.03B | 2.49% | 731,524 | 909.05M |
| 56 | VKTX | Viking Therapeutics, Inc. | 3.99B | 3.98% | 1,075,587 | - |
| 57 | MIRM | Mirum Pharmaceuticals, Inc. | 3.98B | 10.16% | 746,682 | 471.79M |
| 58 | NAMS | NewAmsterdam Pharma Company N.V. | 3.98B | 3.50% | 346,453 | 35.24M |
| 59 | ACLX | Arcellx, Inc. | 3.74B | 0.76% | 266,813 | 35.90M |
| 60 | CNTA | Centessa Pharmaceuticals plc | 3.66B | 0.85% | 195,454 | 15.00M |
| 61 | VERA | Vera Therapeutics, Inc. | 3.58B | 5.85% | 486,963 | - |
| 62 | ARQT | Arcutis Biotherapeutics, Inc. | 3.47B | 2.09% | 821,184 | 317.93M |
| 63 | XENE | Xenon Pharmaceuticals Inc. | 3.42B | 2.36% | 228,294 | 7.50M |
| 64 | TARS | Tarsus Pharmaceuticals, Inc. | 3.38B | 2.92% | 150,171 | 366.10M |
| 65 | RARE | Ultragenyx Pharmaceutical Inc. | 3.23B | 2.01% | 375,836 | 630.60M |
| 66 | IRON | Disc Medicine, Inc. | 3.20B | -6.25% | 2,215,948 | - |
| 67 | TVTX | Travere Therapeutics, Inc. | 3.19B | 3.22% | 447,985 | 435.83M |
| 68 | NUVB | Nuvation Bio Inc. | 3.17B | 2.89% | 2,084,138 | 26.75M |
| 69 | CGON | CG Oncology, Inc. | 3.17B | 3.32% | 203,525 | 2.17M |
| 70 | APLS | Apellis Pharmaceuticals, Inc. | 3.15B | 1.84% | 542,554 | 1.02B |
| 71 | VRDN | Viridian Therapeutics, Inc. | 3.04B | 0.79% | 678,458 | 70.79M |
| 72 | MLYS | Mineralys Therapeutics, Inc. | 3.02B | 3.05% | 367,861 | - |
| 73 | WVE | Wave Life Sciences Ltd. | 3.00B | 5.44% | 1,332,979 | 109.23M |
| 74 | IDYA | IDEAYA Biosciences, Inc. | 2.96B | 1.56% | 232,308 | 214.83M |
| 75 | LQDA | Liquidia Corporation | 2.96B | 1.10% | 559,575 | 69.22M |
| 76 | CPRX | Catalyst Pharmaceuticals, Inc. | 2.95B | 1.44% | 458,059 | 578.20M |
| 77 | DYN | Dyne Therapeutics, Inc. | 2.84B | 7.22% | 1,046,486 | - |
| 78 | OCUL | Ocular Therapeutix, Inc. | 2.75B | -0.46% | 2,249,519 | 55.78M |
| 79 | RCUS | Arcus Biosciences, Inc. | 2.73B | 0.32% | 276,414 | 240.00M |
| 80 | AAPG | Ascentage Pharma Group International | 2.67B | 1.47% | 73 | 54.52M |
| 81 | BEAM | Beam Therapeutics Inc. | 2.66B | 3.13% | 337,525 | 55.70M |
| 82 | TLX | Telix Pharmaceuticals Limited | 2.65B | 1.54% | 38,029 | 664.23M |
| 83 | SYRE | Spyre Therapeutics, Inc. | 2.64B | 1.67% | 365,515 | - |
| 84 | SLNO | Soleno Therapeutics, Inc. | 2.59B | -0.48% | 518,405 | 98.68M |
| 85 | ADPT | Adaptive Biotechnologies Corporation | 2.57B | 2.18% | 450,274 | 252.75M |
| 86 | EWTX | Edgewise Therapeutics, Inc. | 2.56B | 14.37% | 1,261,102 | - |
| 87 | DNLI | Denali Therapeutics Inc. | 2.52B | 2.27% | 404,215 | - |
| 88 | MESO | Mesoblast Limited | 2.47B | 5.48% | 154,291 | 17.20M |
| 89 | OLMA | Olema Pharmaceuticals, Inc. | 2.32B | -4.25% | 1,097,559 | - |
| 90 | RXRX | Recursion Pharmaceuticals, Inc. | 2.28B | -1.13% | 16,028,656 | 43.69M |
| 91 | SRPT | Sarepta Therapeutics, Inc. | 2.24B | 4.87% | 870,685 | 2.41B |
| 92 | HRMY | Harmony Biosciences Holdings, Inc. | 2.19B | 1.28% | 118,798 | 825.94M |
| 93 | AUPH | Aurinia Pharmaceuticals Inc. | 2.14B | 2.14% | 427,363 | 265.81M |
| 94 | GLPG | Galapagos NV | 2.09B | 2.59% | 89,151 | 336.64M |
| 95 | IBRX | ImmunityBio, Inc. | 2.08B | 0.96% | 3,723,844 | 82.56M |
| 96 | ZYME | Zymeworks Inc. | 2.02B | 2.20% | 207,869 | 134.48M |
| 97 | ZLAB | Zai Lab Limited | 2.01B | 5.41% | 594,754 | 441.63M |
| 98 | MAZE | Maze Therapeutics, Inc. | 2.01B | 2.68% | 162,535 | 2.50M |
| 99 | ZBIO | Zenas BioPharma, Inc. | 2.00B | 6.16% | 99,974 | 15.00M |
| 100 | IMNM | Immunome, Inc. | 1.95B | 6.82% | 2,246,671 | 9.68M |
| 101 | SION | Sionna Therapeutics, Inc. | 1.92B | -2.44% | 80,089 | - |
| 102 | NRIX | Nurix Therapeutics, Inc. | 1.87B | 2.67% | 490,894 | 83.69M |
| 103 | MNKD | MannKind Corporation | 1.85B | 1.17% | 1,011,125 | 313.79M |
| 104 | DNTH | Dianthus Therapeutics, Inc. | 1.85B | 3.39% | 334,914 | 3.08M |
| 105 | STOK | Stoke Therapeutics, Inc. | 1.83B | 0.31% | 190,102 | 205.63M |
| 106 | IMCR | Immunocore Holdings plc | 1.83B | 0.84% | 110,281 | 379.59M |
| 107 | VCEL | Vericel Corporation | 1.82B | -0.75% | 188,510 | 258.72M |
| 108 | SNDX | Syndax Pharmaceuticals, Inc. | 1.79B | 1.83% | 295,463 | 111.30M |
| 109 | CLDX | Celldex Therapeutics, Inc. | 1.69B | 0.51% | 182,751 | 2.60M |
| 110 | FTRE | Fortrea Holdings Inc. | 1.64B | 7.13% | 570,065 | 2.76B |
| 111 | PHVS | Pharvaris N.V. | 1.64B | 5.33% | 71,968 | - |
| 112 | TRVI | Trevi Therapeutics, Inc. | 1.63B | 4.18% | 617,213 | - |
| 113 | UPB | Upstream Bio, Inc. | 1.62B | 0.10% | 293,472 | 2.80M |
| 114 | TSHA | Taysha Gene Therapies, Inc. | 1.55B | 4.04% | 1,035,006 | 6.31M |
| 115 | QURE | uniQure N.V. | 1.52B | 1.84% | 1,304,868 | 15.75M |
| 116 | INVA | Innoviva, Inc. | 1.51B | 0.35% | 204,790 | 388.52M |
| 117 | PGEN | Precigen, Inc. | 1.50B | 1.92% | 2,325,692 | 6.31M |
| 118 | CAPR | Capricor Therapeutics, Inc. | 1.49B | 9.81% | 837,306 | 11.13M |
| 119 | RLAY | Relay Therapeutics, Inc. | 1.48B | 5.29% | 726,536 | 8.36M |
| 120 | EYPT | EyePoint, Inc. | 1.48B | 4.57% | 621,618 | 42.34M |
| 121 | RAPP | Rapport Therapeutics, Inc. | 1.47B | 4.01% | 93,935 | - |
| 122 | BHVN | Biohaven Ltd. | 1.47B | -0.54% | 786,102 | - |
| 123 | KOD | Kodiak Sciences Inc. | 1.46B | 4.89% | 291,802 | - |
| 124 | SVRA | Savara Inc. | 1.46B | -0.25% | 604,459 | - |
| 125 | ORKA | Oruka Therapeutics, Inc. | 1.45B | 6.71% | 175,174 | - |
| 126 | AGIO | Agios Pharmaceuticals, Inc. | 1.45B | 0.83% | 385,595 | 44.79M |
| 127 | ATAI | Atai Beckley N.V. | 1.43B | 1.02% | 1,185,513 | 3.02M |
| 128 | ARDX | Ardelyx, Inc. | 1.40B | 1.67% | 746,886 | 398.23M |
| 129 | ANAB | AnaptysBio, Inc. | 1.37B | 3.81% | 169,719 | 169.47M |
| 130 | MBX | MBX Biosciences, Inc. | 1.35B | 4.81% | 507,395 | - |
| 131 | AMLX | Amylyx Pharmaceuticals, Inc. | 1.33B | 1.43% | 995,420 | -665.00K |
| 132 | SEPN | Septerna, Inc. | 1.32B | 7.30% | 142,632 | 22.05M |
| 133 | TYRA | Tyra Biosciences, Inc. | 1.32B | 7.31% | 406,401 | - |
| 134 | INBX | Inhibrx Biosciences, Inc. | 1.30B | 5.06% | 96,118 | 1.40M |
| 135 | MNMD | Mind Medicine (MindMed) Inc. | 1.25B | 1.52% | 434,292 | - |
| 136 | IMTX | Immatics N.V. | 1.23B | 5.85% | 89,477 | 99.45M |
| 137 | OCS | Oculis Holding AG | 1.23B | 9.29% | 152,220 | 992.00K |
| 138 | XERS | Xeris Biopharma Holdings, Inc. | 1.22B | 4.92% | 647,750 | 266.14M |
| 139 | PHAT | Phathom Pharmaceuticals, Inc. | 1.21B | 6.39% | 884,849 | 147.19M |
| 140 | SANA | Sana Biotechnology, Inc. | 1.21B | 0.56% | 1,249,039 | - |
| 141 | PVLA | Palvella Therapeutics, Inc. | 1.19B | 4.14% | 148,879 | - |
| 142 | ALMS | Alumis Inc. | 1.17B | 1.36% | 276,310 | 22.12M |
| 143 | TNGX | Tango Therapeutics, Inc. | 1.17B | 2.36% | 469,946 | 66.50M |
| 144 | XNCR | Xencor, Inc. | 1.13B | 0.89% | 167,709 | 150.13M |
| 145 | PHAR | Pharming Group N.V. | 1.12B | -0.24% | 4,831 | 362.27M |
| 146 | NVAX | Novavax, Inc. | 1.11B | 2.25% | 1,196,312 | 1.06B |
| 147 | NTLA | Intellia Therapeutics, Inc. | 1.09B | 6.36% | 1,834,739 | 57.53M |
| 148 | ABCL | AbCellera Biologics Inc. | 1.08B | 2.55% | 1,169,349 | 35.33M |
| 149 | URGN | UroGen Pharma Ltd. | 1.08B | 6.31% | 171,626 | 96.52M |
| 150 | SPRY | ARS Pharmaceuticals, Inc. | 1.07B | 9.88% | 1,184,419 | 142.77M |
| 151 | NBTX | Nanobiotix S.A. | 1.06B | 0.09% | 30,830 | 11.93M |
| 152 | MDXG | MiMedx Group, Inc. | 1.05B | -2.62% | 249,412 | 393.44M |
| 153 | ERAS | Erasca, Inc. | 1.04B | 1.81% | 349,700 | - |
| 154 | GLUE | Monte Rosa Therapeutics, Inc. | 1.04B | 0.63% | 364,753 | 181.54M |
| 155 | IOVA | Iovance Biotherapeutics, Inc. | 1.02B | 4.07% | 4,804,627 | 250.43M |
| 156 | BCAX | Bicara Therapeutics Inc. | 997.58M | 3.23% | 74,499 | - |
| 157 | ELVN | Enliven Therapeutics, Inc. | 996.44M | 0.66% | 219,054 | - |
| 158 | DAWN | Day One Biopharmaceuticals, Inc. | 986.71M | -3.61% | 1,370,219 | 133.67M |
| 159 | RAPT | RAPT Therapeutics, Inc. | 980.13M | 3.91% | 85,258 | - |
| 160 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 979.86M | 1.62% | 114,938 | - |
| 161 | MLTX | MoonLake Immunotherapeutics | 949.98M | 0.38% | 355,545 | - |
| 162 | CRMD | CorMedix Inc. | 939.95M | 0.08% | 718,686 | 214.30M |
| 163 | TBPH | Theravance Biopharma, Inc. | 937.44M | 1.76% | 85,369 | 80.33M |
| 164 | NKTR | Nektar Therapeutics | 935.51M | 4.52% | 301,440 | 62.60M |
| 165 | CVAC | CureVac N.V. | 933.38M | -3.15% | 2,176,867 | 83.00M |
| 166 | AVBP | ArriVent BioPharma, Inc. | 918.92M | 5.15% | 123,725 | - |
| 167 | CMPX | Compass Therapeutics, Inc. | 915.10M | 2.08% | 461,506 | 850.00K |
| 168 | MRVI | Maravai LifeSciences Holdings, Inc. | 901.37M | 0.14% | 250,464 | 192.44M |
| 169 | ABUS | Arbutus Biopharma Corporation | 882.77M | 1.10% | 244,392 | 14.61M |
| 170 | MPLT | MapLight Therapeutics, Inc. | 878.28M | 0.93% | 89,694 | - |
| 171 | KURA | Kura Oncology, Inc. | 869.31M | 1.42% | 375,002 | 104.03M |
| 172 | JANX | Janux Therapeutics, Inc. | 852.29M | 0.93% | 838,748 | 10.00M |
| 173 | GERN | Geron Corporation | 852.20M | -0.37% | 1,995,744 | 183.40M |
| 174 | FULC | Fulcrum Therapeutics, Inc. | 839.14M | 4.61% | 253,259 | 80.00M |
| 175 | IVA | Inventiva S.A. | 825.50M | - | 128,288 | 19.93M |
| 176 | VIR | Vir Biotechnology, Inc. | 819.45M | -0.67% | 933,197 | 16.86M |
| 177 | GOSS | Gossamer Bio, Inc. | 817.04M | 2.92% | 1,404,819 | 44.05M |
| 178 | YDES | YD Bio Limited | 815.01M | 2.25% | 24,277 | 510.36K |
| 179 | GHRS | GH Research PLC | 802.04M | 1.65% | 122,742 | - |
| 180 | JBIO | Jade Biosciences, Inc. | 794.49M | 4.29% | 172,959 | - |
| 181 | ORIC | ORIC Pharmaceuticals, Inc. | 792.75M | 0.68% | 390,488 | - |
| 182 | ANNX | Annexon, Inc. | 785.52M | 9.34% | 1,280,112 | - |
| 183 | REPL | Replimune Group, Inc. | 782.86M | 2.99% | 353,611 | - |
| 184 | RIGL | Rigel Pharmaceuticals, Inc. | 780.51M | 2.94% | 88,762 | 282.08M |
| 185 | DBVT | DBV Technologies S.A. | 776.40M | -1.86% | 156,042 | 5.50M |
| 186 | KALV | KalVista Pharmaceuticals, Inc. | 776.39M | 2.40% | 273,970 | 1.43M |
| 187 | RGNX | REGENXBIO Inc. | 765.93M | 11.99% | 278,774 | 161.32M |
| 188 | ARVN | Arvinas, Inc. | 741.79M | 2.39% | 220,059 | 312.30M |
| 189 | LXEO | Lexeo Therapeutics, Inc. | 741.55M | 2.01% | 482,451 | - |
| 190 | ATXS | Astria Therapeutics, Inc. | 733.83M | 1.14% | 823,131 | 706.00K |
| 191 | PROK | ProKidney Corp. | 709.97M | -4.45% | 437,759 | 744.00K |
| 192 | VALN | Valneva SE | 703.78M | 1.47% | 12,325 | 211.09M |
| 193 | OMER | Omeros Corporation | 694.82M | 6.99% | 553,494 | - |
| 194 | LYEL | Lyell Immunopharma, Inc. | 693.52M | 0.94% | 25,880 | 41.00K |
| 195 | CTMX | CytomX Therapeutics, Inc. | 682.82M | 3.87% | 623,502 | 113.63M |
| 196 | PRME | Prime Medicine, Inc. | 663.89M | 4.17% | 1,433,999 | 5.98M |
| 197 | MGTX | MeiraGTx Holdings plc | 653.59M | 2.01% | 112,990 | 27.42M |
| 198 | GYRE | Gyre Therapeutics, Inc. | 648.96M | -2.86% | 78,460 | 107.27M |
| 199 | ANRO | Alto Neuroscience, Inc. | 630.96M | 4.42% | 298,435 | - |
| 200 | DRUG | Bright Minds Biosciences Inc. | 622.48M | 9.34% | 42,398 | - |
| 201 | KROS | Keros Therapeutics, Inc. | 608.41M | -0.79% | 189,169 | 246.72M |
| 202 | VSTM | Verastem, Inc. | 605.88M | 1.29% | 1,157,176 | 13.38M |
| 203 | VTYX | Ventyx Biosciences, Inc. | 593.70M | 7.49% | 574,244 | - |
| 204 | CGEM | Cullinan Therapeutics, Inc. | 587.22M | -0.40% | 255,028 | - |
| 205 | ENGN | enGene Holdings Inc. | 573.10M | 4.90% | 45,355 | - |
| 206 | LENZ | LENZ Therapeutics, Inc. | 568.23M | 6.39% | 304,121 | 17.50M |
| 207 | CRVS | Corvus Pharmaceuticals, Inc. | 566.09M | -0.79% | 291,421 | - |
| 208 | DSGN | Design Therapeutics, Inc. | 557.39M | 8.60% | 515,087 | - |
| 209 | TENX | Tenax Therapeutics, Inc. | 551.76M | 6.08% | 109,250 | - |
| 210 | IVVD | Invivyd, Inc. | 550.17M | 3.06% | 975,094 | 50.04M |
| 211 | NBY | NovaBay Pharmaceuticals, Inc. | 548.15M | 47.46% | 3,239,904 | 10.30M |
| 212 | ASMB | Assembly Biosciences, Inc. | 545.69M | 6.65% | 70,370 | 37.19M |
| 213 | EVMN | Evommune, Inc. | 542.84M | 14.72% | 132,545 | 13.00M |
| 214 | NAGE | Niagen Bioscience, Inc. | 522.98M | 0.46% | 199,293 | 124.71M |
| 215 | ABSI | Absci Corporation | 521.79M | 1.76% | 1,058,608 | 2.82M |
| 216 | LBRX | LB Pharmaceuticals Inc | 513.07M | 2.94% | 228,540 | - |
| 217 | FDMT | 4D Molecular Therapeutics, Inc. | 511.93M | 3.11% | 480,199 | 120.00K |
| 218 | PRTA | Prothena Corporation plc | 510.85M | 1.17% | 214,726 | 11.79M |
| 219 | FBRX | Forte Biosciences, Inc. | 508.73M | -0.73% | 51,316 | - |
| 220 | ADCT | ADC Therapeutics SA | 493.65M | 2.18% | 716,929 | 75.21M |
| 221 | BCYC | Bicycle Therapeutics plc | 473.78M | 0.89% | 86,406 | 28.34M |
| 222 | DNA | Ginkgo Bioworks Holdings, Inc. | 472.88M | 0.97% | 437,735 | 180.61M |
| 223 | NBP | NovaBridge Biosciences | 472.59M | 3.54% | 97,489 | - |
| 224 | ZVRA | Zevra Therapeutics, Inc. | 470.08M | 3.09% | 225,285 | 84.39M |
| 225 | MNPR | Monopar Therapeutics Inc. | 461.37M | 4.62% | 100,769 | - |
| 226 | SLDB | Solid Biosciences Inc. | 458.11M | 11.36% | 659,617 | - |
| 227 | OCGN | Ocugen, Inc. | 448.18M | -0.35% | 1,472,637 | 5.37M |
| 228 | VTVT | vTv Therapeutics Inc. | 446.72M | 3.69% | 5,031 | 17.00K |
| 229 | AUTL | Autolus Therapeutics plc | 441.80M | 5.73% | 914,478 | 51.13M |
| 230 | DMAC | DiaMedica Therapeutics Inc. | 439.01M | 1.44% | 132,060 | - |
| 231 | ENTA | Enanta Pharmaceuticals, Inc. | 436.98M | 4.20% | 99,468 | 65.32M |
| 232 | DRTS | Alpha Tau Medical Ltd. | 423.66M | -0.82% | 20,570 | - |
| 233 | ALT | Altimmune, Inc. | 416.85M | -20.89% | 12,710,152 | 20.00K |
| 234 | LXRX | Lexicon Pharmaceuticals, Inc. | 412.46M | -3.81% | 1,075,724 | 70.86M |
| 235 | VNDA | Vanda Pharmaceuticals Inc. | 409.24M | 3.82% | 450,538 | 212.07M |
| 236 | LCTX | Lineage Cell Therapeutics, Inc. | 405.90M | -4.29% | 1,076,729 | 10.82M |
| 237 | PRTC | PureTech Health plc | 404.65M | - | 2 | 6.39M |
| 238 | TRDA | Entrada Therapeutics, Inc. | 397.70M | 1.19% | 68,481 | 61.52M |
| 239 | BNTC | Benitec Biopharma Inc. | 389.42M | 1.05% | 33,290 | - |
| 240 | IMMP | Immutep Limited | 385.51M | -0.76% | 118,948 | 3.31M |
| 241 | PEPG | PepGen Inc. | 382.24M | 6.92% | 123,953 | - |
| 242 | IMRX | Immuneering Corporation | 373.86M | 2.12% | 459,884 | - |
| 243 | TECX | Tectonic Therapeutic, Inc. | 373.02M | 8.49% | 174,200 | - |
| 244 | AURA | Aura Biosciences, Inc. | 368.95M | 0.52% | 43,111 | - |
| 245 | CYBN | Cybin Inc. | 356.31M | 5.47% | 454,684 | - |
| 246 | RCKT | Rocket Pharmaceuticals, Inc. | 352.26M | 0.77% | 505,468 | - |
| 247 | AVXL | Anavex Life Sciences Corp. | 348.90M | 0.39% | 646,438 | - |
| 248 | AVTX | Avalo Therapeutics, Inc. | 346.54M | 1.06% | 111,662 | 192.00K |
| 249 | ACRS | Aclaris Therapeutics, Inc. | 345.62M | 3.57% | 259,114 | 15.74M |
| 250 | CTNM | Contineum Therapeutics, Inc. | 343.48M | 3.34% | 33,377 | - |
| 251 | SLS | SELLAS Life Sciences Group, Inc. | 339.01M | 1.71% | 2,450,365 | - |
| 252 | MREO | Mereo BioPharma Group plc | 329.40M | 7.81% | 1,451,522 | 500.00K |
| 253 | ALLO | Allogene Therapeutics, Inc. | 321.36M | 0.70% | 3,384,656 | 22.00K |
| 254 | RLMD | Relmada Therapeutics, Inc. | 321.20M | 5.54% | 225,018 | - |
| 255 | EPRX | Eupraxia Pharmaceuticals Inc. | 320.18M | 6.96% | 302,119 | - |
| 256 | NGNE | Neurogene Inc. | 319.48M | 6.98% | 99,258 | 925.00K |
| 257 | KYTX | Kyverna Therapeutics, Inc. | 318.40M | 3.86% | 1,020,193 | - |
| 258 | XFOR | X4 Pharmaceuticals, Inc. | 318.27M | -0.55% | 247,167 | 33.98M |
| 259 | XOMA | XOMA Royalty Corporation | 313.54M | 1.69% | 102,256 | 47.11M |
| 260 | FHTX | Foghorn Therapeutics Inc. | 313.29M | 10.80% | 199,774 | 24.52M |
| 261 | LRMR | Larimar Therapeutics, Inc. | 308.55M | 5.10% | 776,607 | - |
| 262 | AARD | Aardvark Therapeutics, Inc. | 307.66M | 3.21% | 46,928 | - |
| 263 | CADL | Candel Therapeutics, Inc. | 306.88M | 0.90% | 261,858 | - |
| 264 | GUTS | Fractyl Health, Inc. | 304.24M | -1.77% | 1,361,995 | 3.00K |
| 265 | ALDX | Aldeyra Therapeutics, Inc. | 303.82M | 0.80% | 335,199 | - |
| 266 | CAMP | Camp4 Therapeutics Corporation | 300.04M | 3.06% | 49,409 | 3.80M |
| 267 | OABI | OmniAb, Inc. | 299.43M | 3.48% | 170,469 | 21.09M |
| 268 | ACIU | AC Immune SA | 298.81M | 2.37% | 107,767 | 5.48M |
| 269 | CLLS | Cellectis S.A. | 298.52M | 4.57% | 14,178 | 82.55M |
| 270 | SLN | Silence Therapeutics plc | 297.57M | 1.12% | 30,875 | 25.83M |
| 271 | NMRA | Neumora Therapeutics, Inc. | 297.39M | 1.74% | 293,756 | - |
| 272 | CLYM | Climb Bio, Inc. | 294.56M | -1.37% | 420,439 | - |
| 273 | VOR | Vor Biopharma Inc. | 284.62M | 1.48% | 488,969 | - |
| 274 | PBYI | Puma Biotechnology, Inc. | 284.21M | 0.36% | 114,578 | 212.00M |
| 275 | ZURA | Zura Bio Limited | 278.62M | 0.35% | 94,664 | - |
| 276 | ABEO | Abeona Therapeutics Inc. | 276.92M | 3.86% | 307,942 | 400.00K |
| 277 | TARA | Protara Therapeutics, Inc. | 275.97M | 3.19% | 283,676 | - |
| 278 | PALI | Palisade Bio, Inc. | 264.48M | 6.29% | 664,833 | - |
| 279 | FENC | Fennec Pharmaceuticals Inc. | 259.57M | 0.26% | 40,106 | 38.79M |
| 280 | GALT | Galectin Therapeutics Inc. | 257.89M | -35.06% | 2,711,901 | - |
| 281 | AVIR | Atea Pharmaceuticals, Inc. | 246.10M | 0.64% | 77,339 | - |
| 282 | CBIO | Crescent Biopharma, Inc. | 244.86M | 2.50% | 57,481 | - |
| 283 | NAUT | Nautilus Biotechnology, Inc. | 243.77M | -0.52% | 140,912 | - |
| 284 | MDWD | MediWound Ltd. | 242.97M | 0.58% | 22,009 | 20.93M |
| 285 | HRTX | Heron Therapeutics, Inc. | 239.29M | 1.16% | 554,947 | 155.10M |
| 286 | OBIO | Orchestra BioMed Holdings, Inc. | 238.28M | -2.76% | 40,260 | 2.82M |
| 287 | EDIT | Editas Medicine, Inc. | 237.21M | 3.40% | 551,664 | 46.38M |
| 288 | CABA | Cabaletta Bio, Inc. | 232.48M | 0.21% | 545,649 | - |
| 289 | VYGR | Voyager Therapeutics, Inc. | 229.63M | 0.24% | 114,013 | 31.32M |
| 290 | ACHV | Achieve Life Sciences, Inc. | 228.91M | -0.92% | 287,169 | - |
| 291 | PRQR | ProQR Therapeutics N.V. | 226.49M | 2.38% | 496,833 | 18.86M |
| 292 | MIST | Milestone Pharmaceuticals Inc. | 217.89M | 3.12% | 3,390,071 | - |
| 293 | HUMA | Humacyte, Inc. | 214.43M | 3.15% | 1,976,563 | 1.57M |
| 294 | TNXP | Tonix Pharmaceuticals Holding Corp. | 205.03M | -4.39% | 278,281 | 10.30M |
| 295 | NVCT | Nuvectis Pharma, Inc. | 203.89M | -0.25% | 29,432 | - |
| 296 | QNCX | Quince Therapeutics, Inc. | 202.68M | 4.60% | 265,904 | - |
| 297 | CCCC | C4 Therapeutics, Inc. | 199.64M | 2.49% | 546,459 | 30.11M |
| 298 | ARMP | Armata Pharmaceuticals, Inc. | 198.78M | 1.11% | 24,101 | 5.05M |
| 299 | SGMT | Sagimet Biosciences Inc. | 197.41M | 1.85% | 228,734 | - |
| 300 | RNAC | Cartesian Therapeutics, Inc. | 197.24M | 3.06% | 48,970 | 1.09M |
| 301 | IMMX | Immix Biopharma, Inc. | 194.42M | 1.40% | 290,091 | - |
| 302 | STTK | Shattuck Labs, Inc. | 188.57M | 0.68% | 28,114 | 1.00M |
| 303 | IKT | Inhibikase Therapeutics, Inc. | 188.56M | -3.59% | 110,524 | 1.00 |
| 304 | SABS | SAB Biotherapeutics, Inc. | 188.52M | 0.25% | 210,222 | 114.70K |
| 305 | ARCT | Arcturus Therapeutics Holdings Inc. | 185.53M | 1.56% | 193,939 | 97.60M |
| 306 | DWTX | Dogwood Therapeutics, Inc. | 184.76M | 1.89% | 6,403 | - |
| 307 | SRZN | Surrozen, Inc. | 183.60M | -0.33% | 31,859 | 3.60M |
| 308 | RANI | Rani Therapeutics Holdings, Inc. | 181.07M | -1.97% | 746,273 | 1.20M |
| 309 | GLSI | Greenwich LifeSciences, Inc. | 177.19M | 3.22% | 141,714 | - |
| 310 | KLRS | Kalaris Therapeutics, Inc. | 175.62M | -9.88% | 78,417 | - |
| 311 | TLSA | Tiziana Life Sciences Ltd | 174.67M | 2.08% | 247,888 | - |
| 312 | CRDF | Cardiff Oncology, Inc. | 171.43M | 1.80% | 235,522 | 501.00K |
| 313 | RZLT | Rezolute, Inc. | 168.76M | -1.62% | 3,958,285 | - |
| 314 | CHRS | Coherus Oncology, Inc. | 168.62M | 2.57% | 267,486 | 277.73M |
| 315 | IPHA | Innate Pharma S.A. | 167.97M | -3.41% | 13,994 | 14.84M |
| 316 | PRLD | Prelude Therapeutics Incorporated | 164.79M | 4.17% | 63,117 | 10.50M |
| 317 | ACTU | Actuate Therapeutics, Inc. | 161.77M | -0.85% | 14,550 | - |
| 318 | INO | Inovio Pharmaceuticals, Inc. | 161.45M | -0.84% | 689,617 | 182.34K |
| 319 | MOLN | Molecular Partners AG | 158.37M | 2.57% | 1,665 | 856.30K |
| 320 | ALEC | Alector, Inc. | 156.09M | 2.88% | 585,841 | 69.05M |
| 321 | GNLX | Genelux Corporation | 155.55M | -1.31% | 63,912 | 8.00K |
| 322 | CRBU | Caribou Biosciences, Inc. | 154.69M | 1.53% | 309,648 | 9.30M |
| 323 | SGMO | Sangamo Therapeutics, Inc. | 152.36M | 5.30% | 1,785,992 | 32.88M |
| 324 | CRBP | Corbus Pharmaceuticals Holdings, Inc. | 149.90M | -0.12% | 76,145 | - |
| 325 | CDXS | Codexis, Inc. | 148.13M | - | 149,503 | 52.93M |
| 326 | MRSN | Mersana Therapeutics, Inc. | 145.66M | 0.14% | 11,224 | 33.18M |
| 327 | CGEN | Compugen Ltd. | 144.51M | 2.32% | 112,570 | 6.90M |
| 328 | PLX | Protalix BioTherapeutics, Inc. | 144.36M | -0.28% | 328,499 | 61.84M |
| 329 | BDTX | Black Diamond Therapeutics, Inc. | 143.29M | -0.98% | 479,686 | 70.00M |
| 330 | ELTX | Elicio Therapeutics, Inc. | 141.90M | 1.63% | 42,917 | - |
| 331 | CGTX | Cognition Therapeutics, Inc. | 137.58M | 3.90% | 584,973 | - |
| 332 | IRD | Opus Genetics, Inc. | 135.86M | -0.51% | 144,231 | 14.63M |
| 333 | ETHZ | ETHZilla Corporation | 135.77M | 7.08% | 437,083 | 4.11M |
| 334 | ABOS | Acumen Pharmaceuticals, Inc. | 133.26M | 3.77% | 190,011 | - |
| 335 | SPRO | Spero Therapeutics, Inc. | 130.70M | 1.31% | 263,389 | 40.55M |
| 336 | VRCA | Verrica Pharmaceuticals Inc. | 130.48M | 0.62% | 93,179 | 30.83M |
| 337 | MCRB | Seres Therapeutics, Inc. | 130.45M | -5.63% | 107,407 | 351.00K |
| 338 | FATE | Fate Therapeutics, Inc. | 127.46M | 5.24% | 661,499 | 7.14M |
| 339 | NKTX | Nkarta, Inc. | 127.14M | 1.70% | 151,201 | - |
| 340 | NTHI | NeOnc Technologies Holdings, Inc. | 125.03M | -8.55% | 23,699 | 59.99K |
| 341 | ATRA | Atara Biotherapeutics, Inc. | 124.34M | 0.09% | 20,440 | 151.93M |
| 342 | CNTB | Connect Biopharma Holdings Limited | 124.11M | -3.48% | 140,409 | 762.00K |
| 343 | ELDN | Eledon Pharmaceuticals, Inc. | 123.24M | 4.46% | 320,787 | - |
| 344 | ARTV | Artiva Biotherapeutics, Inc. | 121.99M | 6.88% | 249,123 | 251.00K |
| 345 | WHWK | Whitehawk Therapeutics, Inc. | 121.36M | 6.40% | 119,660 | 14.38M |
| 346 | AGEN | Agenus Inc. | 120.39M | 0.85% | 2,432,968 | 106.83M |
| 347 | UNCY | Unicycive Therapeutics, Inc. | 117.77M | 1.48% | 114,118 | - |
| 348 | KPTI | Karyopharm Therapeutics Inc. | 117.48M | 8.16% | 89,344 | 142.53M |
| 349 | SLGL | Sol-Gel Technologies Ltd. | 117.45M | -1.38% | 4,054 | 18.97M |
| 350 | ACOG | Alpha Cognition Inc. | 117.08M | 6.63% | 98,938 | 7.43M |
| 351 | ORMP | Oramed Pharmaceuticals Inc. | 116.22M | -2.01% | 72,964 | 2.00M |
| 352 | CNTX | Context Therapeutics Inc. | 115.77M | 9.57% | 555,436 | - |
| 353 | TNYA | Tenaya Therapeutics, Inc. | 114.57M | 3.01% | 1,539,392 | - |
| 354 | COYA | Coya Therapeutics, Inc. | 111.95M | 0.94% | 89,805 | 3.99M |
| 355 | FBIO | Fortress Biotech, Inc. | 109.56M | 6.33% | 233,183 | 62.30M |
| 356 | DTIL | Precision BioSciences, Inc. | 109.29M | 0.44% | 57,893 | 698.00K |
| 357 | ONCY | Oncolytics Biotech Inc. | 108.26M | 0.98% | 136,649 | - |
| 358 | SAVA | Cassava Sciences, Inc. | 107.73M | -21.75% | 3,372,965 | - |
| 359 | ANIX | Anixa Biosciences, Inc. | 107.64M | 0.93% | 173,770 | - |
| 360 | VANI | Vivani Medical, Inc. | 105.05M | 4.35% | 76,720 | - |
| 361 | OVID | Ovid Therapeutics Inc. | 103.61M | 8.58% | 1,344,374 | 6.61M |
| 362 | ZNTL | Zentalis Pharmaceuticals, Inc. | 101.51M | -1.06% | 270,182 | 26.87M |
| 363 | EXOZ | eXoZymes, Inc. | 100.65M | -1.64% | 262 | -700.00 |
| 364 | SEER | Seer, Inc. | 100.51M | -1.01% | 80,572 | 16.38M |
| 365 | GANX | Gain Therapeutics, Inc. | 100.00M | 15.56% | 9,922,723 | - |
| 366 | MGNX | MacroGenics, Inc. | 99.00M | -0.32% | 338,529 | 127.63M |
| 367 | CSBR | Champions Oncology, Inc. | 98.87M | -1.39% | 4,040 | 58.42M |
| 368 | BMEA | Biomea Fusion, Inc. | 94.74M | -0.74% | 417,521 | - |
| 369 | ANVS | Annovis Bio, Inc. | 94.62M | -2.72% | 405,001 | - |
| 370 | PYXS | Pyxis Oncology, Inc. | 93.40M | -13.29% | 2,230,006 | 2.82M |
| 371 | RPTX | Repare Therapeutics Inc. | 93.28M | 0.93% | 46,927 | 11.87M |
| 372 | ATOS | Atossa Therapeutics, Inc. | 91.69M | 0.80% | 205,412 | - |
| 373 | TTRX | Turn Therapeutics Inc. | 91.55M | 3.63% | 10,286 | - |
| 374 | ANEB | Anebulo Pharmaceuticals, Inc. | 90.39M | -0.45% | 12,948 | - |
| 375 | ENTX | Entera Bio Ltd. | 88.05M | -1.03% | 83,756 | 124.00K |
| 376 | ADAG | Adagene Inc. | 87.19M | 1.09% | 17,519 | 103.20K |
| 377 | VXRT | Vaxart, Inc. | 86.72M | -1.87% | 105,492 | 148.20M |
| 378 | CBUS | Cibus, Inc. | 86.31M | 3.25% | 22,056 | 3.79M |
| 379 | OTLK | Outlook Therapeutics, Inc. | 84.40M | -8.21% | 3,849,634 | 1.51M |
| 380 | SPRB | Spruce Biosciences, Inc. | 84.00M | 2.23% | 6,013 | 697.00K |
| 381 | THAR | Tharimmune, Inc. | 80.95M | 4.05% | 113,016 | - |
| 382 | STRO | Sutro Biopharma, Inc. | 80.85M | 6.27% | 35,622 | 105.65M |
| 383 | ALXO | ALX Oncology Holdings Inc. | 80.24M | 4.96% | 33,614 | - |
| 384 | ACET | Adicet Bio, Inc. | 79.28M | 4.32% | 1,721,679 | - |
| 385 | COEP | Coeptis Therapeutics Holdings, Inc. | 78.66M | 0.61% | 26,274 | 501.00K |
| 386 | PSTV | Plus Therapeutics, Inc. | 77.65M | 2.45% | 2,879,838 | 5.26M |
| 387 | XBIT | XBiotech Inc. | 77.44M | 0.40% | 7,399 | - |
| 388 | TIL | Instil Bio, Inc. | 77.38M | 2.84% | 16,608 | - |
| 389 | OKYO | OKYO Pharma Limited | 76.73M | 9.09% | 77,134 | - |
| 390 | TVGN | Tevogen Bio Holdings Inc. | 76.63M | 1.31% | 152,330 | - |
| 391 | KRRO | Korro Bio, Inc. | 76.09M | 3.32% | 63,381 | 7.37M |
| 392 | PLRX | Pliant Therapeutics, Inc. | 74.97M | 0.83% | 256,228 | - |
| 393 | HYFT | MindWalk Holdings Corp. | 74.94M | -2.13% | 135,967 | 19.02M |
| 394 | IPSC | Century Therapeutics, Inc. | 74.54M | 11.83% | 2,779,754 | 113.34M |
| 395 | IFRX | InflaRx N.V. | 74.52M | 3.77% | 221,091 | 73.73K |
| 396 | PTHS | Pelthos Therapeutics Inc. | 73.46M | 4.98% | 2,917 | 7.41M |
| 397 | CALC | CalciMedica, Inc. | 72.62M | 2.86% | 24,447 | - |
| 398 | CRVO | CervoMed Inc. | 72.26M | -1.14% | 55,451 | 6.16M |
| 399 | BYSI | BeyondSpring Inc. | 71.55M | -6.95% | 84,386 | 1.88M |
| 400 | ATYR | aTyr Pharma, Inc. | 70.10M | 1.75% | 857,067 | 190.00K |
| 401 | EQ | Equillium, Inc. | 70.03M | 6.48% | 306,505 | 4.39M |
| 402 | ACRV | Acrivon Therapeutics, Inc. | 69.89M | -1.99% | 326,274 | - |
| 403 | MNOV | MediciNova, Inc. | 69.54M | -2.41% | 30,011 | 257.92K |
| 404 | RVPH | Reviva Pharmaceuticals Holdings, Inc. | 68.84M | 2.31% | 1,289,112 | - |
| 405 | IMUX | Immunic, Inc. | 67.84M | -0.46% | 973,880 | - |
| 406 | IMA | ImageneBio, Inc. | 67.31M | 2.10% | 2,045 | 800.00K |
| 407 | MGX | Metagenomi, Inc. | 67.20M | 7.83% | 321,281 | 30.91M |
| 408 | PMVP | PMV Pharmaceuticals, Inc. | 66.25M | 1.22% | 105,218 | - |
| 409 | NRXP | NRx Pharmaceuticals, Inc. | 65.19M | 6.42% | 269,662 | 242.00K |
| 410 | PYPD | PolyPid Ltd. | 65.04M | -0.26% | 7,529 | - |
| 411 | ALGS | Aligos Therapeutics, Inc. | 64.98M | 1.83% | 36,384 | 2.65M |
| 412 | ESLA | Estrella Immunopharma, Inc. | 59.67M | - | 38,092 | - |
| 413 | ATHE | Alterity Therapeutics Limited | 57.62M | 2.00% | 4,512 | 3.57M |
| 414 | ANL | Adlai Nortye Ltd. | 56.46M | -1.29% | 4,405 | 1.94M |
| 415 | INKT | MiNK Therapeutics, Inc. | 55.91M | 3.30% | 26,256 | - |
| 416 | OSTX | OS Therapies Incorporated | 55.81M | -0.94% | 154,275 | - |
| 417 | NTRB | Nutriband Inc. | 55.67M | 1.10% | 2,517 | 2.28M |
| 418 | JSPR | Jasper Therapeutics, Inc. | 54.85M | 5.38% | 623,603 | - |
| 419 | ICCC | ImmuCell Corporation | 54.29M | -2.25% | 1,926 | 27.77M |
| 420 | TCRX | TScan Therapeutics, Inc. | 52.11M | -1.37% | 417,727 | 8.42M |
| 421 | LITS | Lite Strategy, Inc. | 52.05M | 4.81% | 316,712 | - |
| 422 | GRCE | Grace Therapeutics, Inc. | 51.99M | 0.30% | 22,403 | - |
| 423 | ABVC | ABVC BioPharma, Inc. | 50.68M | 5.39% | 70,069 | 797.92K |
| 424 | ATNM | Actinium Pharmaceuticals, Inc. | 49.71M | 0.23% | 36,998 | 90.00K |
| 425 | PDSB | PDS Biotechnology Corporation | 49.27M | 2.74% | 139,148 | - |
| 426 | INMB | INmune Bio, Inc. | 48.65M | 0.55% | 87,786 | 50.00K |
| 427 | TELO | Telomir Pharmaceuticals, Inc. | 48.13M | 2.19% | 95,531 | - |
| 428 | PTN | Palatin Technologies, Inc. | 47.18M | 3.17% | 8,337 | 8.85M |
| 429 | KZR | Kezar Life Sciences, Inc. | 46.72M | 0.95% | 12,072 | - |
| 430 | MAIA | MAIA Biotechnology, Inc. | 46.48M | 4.58% | 172,203 | - |
| 431 | RADX | Radiopharm Theranostics Limited | 46.25M | -1.28% | 125,205 | 8.20M |
| 432 | IOBT | IO Biotech, Inc. | 45.80M | 2.33% | 269,664 | - |
| 433 | BCAB | BioAtla, Inc. | 44.99M | -3.78% | 588,668 | 11.00M |
| 434 | IBO | Impact BioMedical Inc. | 44.99M | -3.11% | 67,530 | 25.00K |
| 435 | IBIO | iBio, Inc. | 44.19M | 4.52% | 575,273 | 500.00K |
| 436 | HURA | TuHURA Biosciences, Inc. | 43.57M | -4.15% | 253,153 | - |
| 437 | CVM | CEL-SCI Corporation | 43.05M | -2.36% | 15,705 | - |
| 438 | EVAX | Evaxion A/S | 41.53M | -13.39% | 192,288 | 7.65M |
| 439 | XCUR | Exicure, Inc. | 41.43M | 6.73% | 63,305 | 500.00K |
| 440 | OKUR | OnKure Therapeutics, Inc. | 40.64M | -3.54% | 98,491 | - |
| 441 | JUNS | Jupiter Neurosciences, Inc. | 39.93M | 3.57% | 35,031 | - |
| 442 | BTAI | BioXcel Therapeutics, Inc. | 39.58M | -1.09% | 149,237 | 752.00K |
| 443 | QTTB | Q32 Bio Inc. | 37.53M | 0.66% | 97,193 | - |
| 444 | TVRD | Tvardi Therapeutics, Inc. | 37.34M | 2.31% | 42,982 | - |
| 445 | LTRN | Lantern Pharma Inc. | 37.24M | 2.78% | 10,866 | - |
| 446 | CELU | Celularity Inc. | 37.11M | 4.80% | 18,517 | 40.58M |
| 447 | GLTO | Galecto, Inc. | 37.02M | 7.27% | 16,478 | - |
| 448 | VERU | Veru Inc. | 36.76M | 1.33% | 135,090 | 16.89M |
| 449 | GBIO | Generation Bio Co. | 36.25M | -1.28% | 20,985 | 15.27M |
| 450 | APLM | Apollomics, Inc. | 36.06M | 11.11% | 22,163 | 198.00K |
| 451 | NXTC | NextCure, Inc. | 35.85M | -1.12% | 7,625 | - |
| 452 | RNTX | Rein Therapeutics Inc. | 35.82M | 5.64% | 55,607 | - |
| 453 | XLO | Xilio Therapeutics, Inc. | 35.25M | 3.29% | 67,309 | 31.80M |
| 454 | RNXT | RenovoRx, Inc. | 35.18M | 6.67% | 76,392 | 928.00K |
| 455 | QNTM | Quantum BioPharma Ltd. | 34.17M | -2.19% | 12,075 | - |
| 456 | FGEN | FibroGen, Inc. | 34.14M | 1.44% | 11,370 | 8.30M |
| 457 | HOWL | Werewolf Therapeutics, Inc. | 33.98M | 8.26% | 897,643 | 1.14M |
| 458 | GNTA | Genenta Science S.p.A. | 33.71M | -2.79% | 196,087 | - |
| 459 | DYAI | Dyadic International, Inc. | 33.30M | 1.13% | 30,480 | 3.34M |
| 460 | PLUR | Pluri Inc. | 32.77M | 2.63% | 17,730 | 1.33M |
| 461 | NRXS | NeurAxis, Inc. | 32.70M | 6.60% | 14,248,945 | 3.36M |
| 462 | RLYB | Rallybio Corporation | 32.46M | -1.22% | 57,744 | 674.00K |
| 463 | ANTX | AN2 Therapeutics, Inc. | 31.65M | 1.32% | 5,721 | - |
| 464 | SNTI | Senti Biosciences, Inc. | 31.55M | 2.56% | 238,366 | - |
| 465 | DARE | Daré Bioscience, Inc. | 31.01M | -4.82% | 121,462 | -57.13K |
| 466 | SKYE | Skye Bioscience, Inc. | 30.96M | -3.42% | 506,617 | - |
| 467 | PASG | Passage Bio, Inc. | 30.80M | 2.65% | 54,454 | - |
| 468 | SER | Serina Therapeutics, Inc. | 29.97M | 5.76% | 2,459 | 116.00K |
| 469 | HYPD | Hyperion DeFi, Inc. | 29.42M | 20.00% | 156,084 | 345.32K |
| 470 | BRNS | Barinthus Biotherapeutics plc | 29.40M | -1.56% | 46,842 | 14.97M |
| 471 | VTGN | Vistagen Therapeutics, Inc. | 28.48M | -2.54% | 4,806,128 | 721.00K |
| 472 | IGC | IGC Pharma, Inc. | 28.33M | -9.22% | 2,479,489 | 1.11M |
| 473 | BOLD | Boundless Bio, Inc. | 27.76M | -2.36% | 33,658 | - |
| 474 | KLTO | Klotho Neurosciences, Inc. | 27.67M | 5.21% | 226,904 | - |
| 475 | ATHA | Athira Pharma, Inc. | 27.06M | 2.08% | 904,848 | - |
| 476 | NERV | Minerva Neurosciences, Inc. | 27.05M | -0.06% | 4,423 | - |
| 477 | CING | Cingulate Inc. | 25.95M | -0.52% | 31,248 | - |
| 478 | LNAI | Lunai Bioworks Inc. | 24.84M | 2.91% | 133,434 | - |
| 479 | INTS | Intensity Therapeutics, Inc. | 24.46M | -2.49% | 385,542 | - |
| 480 | KTTA | Pasithea Therapeutics Corp. | 23.70M | -3.82% | 281,034 | - |
| 481 | LIXT | Lixte Biotechnology Holdings, Inc. | 23.39M | 4.59% | 18,526 | - |
| 482 | LPCN | Lipocine Inc. | 23.15M | -0.71% | 51,490 | 4.32M |
| 483 | NNVC | NanoViricides, Inc. | 22.41M | 2.89% | 155,185 | - |
| 484 | LIMN | Liminatus Pharma, Inc. | 21.65M | -1.22% | 36,390 | - |
| 485 | MRKR | Marker Therapeutics, Inc. | 21.26M | 1.19% | 101,544 | 4.69M |
| 486 | NEUP | Neuphoria Therapeutics Inc. | 20.94M | 0.13% | 16,532 | 15.65M |
| 487 | ITRM | Iterum Therapeutics plc | 20.59M | 2.39% | 97,488 | 390.00K |
| 488 | CUE | Cue Biopharma, Inc. | 19.83M | -26.37% | 2,840,482 | 7.10M |
| 489 | ENLV | Enlivex Therapeutics Ltd. | 19.68M | -2.57% | 245,281 | - |
| 490 | NRSN | NeuroSense Therapeutics Ltd. | 19.46M | -5.04% | 196,998 | - |
| 491 | CTXR | Citius Pharmaceuticals, Inc. | 19.30M | 2.45% | 75,322 | - |
| 492 | KZIA | Kazia Therapeutics Limited | 19.30M | 5.41% | 33,673 | 1.20M |
| 493 | VYNE | VYNE Therapeutics Inc. | 19.24M | -1.20% | 4,780,384 | 524.00K |
| 494 | MTVA | MetaVia Inc. | 19.15M | 4.82% | 7,892 | - |
| 495 | PLRZ | Polyrizon Ltd. | 18.86M | -5.49% | 62,170 | - |
| 496 | PMN | ProMIS Neurosciences, Inc. | 18.79M | 3.68% | 8,109 | - |
| 497 | APLT | Applied Therapeutics, Inc. | 18.61M | 4.37% | 2,416,774 | 1.00M |
| 498 | KAPA | Kairos Pharma, Ltd. | 18.32M | 13.55% | 56,584 | - |
| 499 | LSTA | Lisata Therapeutics, Inc. | 18.17M | 2.49% | 7,969 | 1.07M |
| 500 | GDTC | CytoMed Therapeutics Limited | 18.06M | 0.32% | 10,228 | 573.19K |
| 501 | APVO | Aptevo Therapeutics Inc. | 17.86M | 1.92% | 364,185 | - |
| 502 | CLGN | CollPlant Biotechnologies Ltd. | 17.76M | 0.72% | 6,450 | 2.48M |
| 503 | CASI | CASI Pharmaceuticals, Inc. | 17.26M | 1.02% | 1,653 | 26.85M |
| 504 | BCTX | BriaCell Therapeutics Corp. | 17.13M | 1.84% | 4,720 | - |
| 505 | HOTH | Hoth Therapeutics, Inc. | 16.91M | 1.86% | 42,620 | - |
| 506 | OSRH | OSR Holdings, Inc. | 16.87M | 14.75% | 325,395 | -90.52K |
| 507 | ALLR | Allarity Therapeutics, Inc. | 16.43M | 1.46% | 16,859 | - |
| 508 | FBLG | FibroBiologics, Inc. | 15.87M | -0.77% | 429,196 | - |
| 509 | CANF | Can-Fite BioPharma Ltd. | 15.86M | - | 312,332 | 560.00K |
| 510 | TPST | Tempest Therapeutics, Inc. | 15.27M | 4.03% | 85,482 | - |
| 511 | CVKD | Cadrenal Therapeutics, Inc. | 14.90M | -2.58% | 45,580 | - |
| 512 | NCNA | NuCana plc | 14.52M | 0.58% | 30,537 | - |
| 513 | CRIS | Curis, Inc. | 14.48M | -2.61% | 101,042 | 11.65M |
| 514 | SYBX | Synlogic, Inc. | 14.27M | 7.96% | 7,861 | 8.00K |
| 515 | COCP | Cocrystal Pharma, Inc. | 13.92M | 1.00% | 8,455 | - |
| 516 | BLRX | BioLineRx Ltd. | 13.84M | 0.17% | 8,466 | 12.74M |
| 517 | BCDA | BioCardia, Inc. | 13.30M | -2.11% | 32,592 | 3.00K |
| 518 | SNGX | Soligenix, Inc. | 13.11M | 5.69% | 622,381 | 2.34K |
| 519 | ABP | Abpro Holdings, Inc. | 13.09M | 0.63% | 1,212 | 183.00K |
| 520 | LEXX | Lexaria Bioscience Corp. | 12.69M | -16.65% | 771,847 | 705.92K |
| 521 | CMMB | Chemomab Therapeutics Ltd. | 12.62M | 6.77% | 49,596 | - |
| 522 | AEON | AEON Biopharma, Inc. | 12.43M | 3.97% | 192,840 | - |
| 523 | EDSA | Edesa Biotech, Inc. | 12.25M | -0.29% | 18,149 | - |
| 524 | NCEL | NewcelX Ltd. | 12.16M | -1.59% | 15,630 | - |
| 525 | MBRX | Moleculin Biotech, Inc. | 12.11M | 2.61% | 75,150 | - |
| 526 | CLRB | Cellectar Biosciences, Inc. | 12.04M | 4.80% | 36,002 | - |
| 527 | QNRX | Quoin Pharmaceuticals, Ltd. | 11.91M | 2.75% | 8,635 | - |
| 528 | SNSE | Sensei Biotherapeutics, Inc. | 11.78M | 2.41% | 5,846 | - |
| 529 | IMNN | Imunon, Inc. | 11.67M | 0.26% | 23,496 | - |
| 530 | LGVN | Longeveron Inc. | 11.66M | -0.87% | 75,878 | 1.44M |
| 531 | PHIO | Phio Pharmaceuticals Corp. | 11.52M | 0.94% | 256,095 | - |
| 532 | BIVI | BioVie Inc. | 10.85M | -0.69% | 28,660 | - |
| 533 | ASBP | Aspire Biopharma Holdings, Inc. | 10.69M | -0.80% | 3,954,669 | 1.94K |
| 534 | TRAW | Traws Pharma, Inc. | 10.58M | 5.93% | 169,948 | 2.85M |
| 535 | BRTX | BioRestorative Therapies, Inc. | 10.56M | 0.85% | 20,086 | 383.40K |
| 536 | ERNA | Ernexa Therapeutics Inc. | 10.20M | 3.17% | 5,728 | 1,000.00 |
| 537 | BOLT | Bolt Biotherapeutics, Inc. | 10.06M | 1.65% | 9,848 | 5.20M |
| 538 | PPCB | Propanc Biopharma, Inc. | 9.69M | 0.69% | 8,632 | - |
| 539 | APM | Aptorum Group Limited | 9.65M | 3.83% | 16,776 | - |
| 540 | CLDI | Calidi Biotherapeutics, Inc. | 9.44M | -1.53% | 16,397 | - |
| 541 | EVGN | Evogene Ltd. | 9.08M | 1.18% | 7,502 | 8.02M |
| 542 | AKTX | Akari Therapeutics, Plc | 9.00M | 2.78% | 978,298 | - |
| 543 | PULM | Pulmatrix, Inc. | 8.98M | -33.87% | 141,325 | 3.00K |
| 544 | ICU | SeaStar Medical Holding Corporation | 8.63M | -18.68% | 1,579,606 | 881.00K |
| 545 | TCRT | Alaunos Therapeutics, Inc. | 8.37M | -5.78% | 57,244 | 6.00K |
| 546 | PCSA | Processa Pharmaceuticals, Inc. | 8.32M | -5.90% | 361,985 | - |
| 547 | ALZN | Alzamend Neuro, Inc. | 8.29M | 0.93% | 18,537 | - |
| 548 | ADXN | Addex Therapeutics Ltd | 8.20M | 4.10% | 1,056 | 198.82K |
| 549 | MBIO | Mustang Bio, Inc. | 8.17M | 5.66% | 46,632 | - |
| 550 | CELZ | Creative Medical Technology Holdings, Inc. | 8.02M | -2.25% | 13,579 | 6.00K |
| 551 | IMRN | Immuron Limited | 7.98M | -0.44% | 18,950 | 4.78M |
| 552 | GTBP | GT Biopharma, Inc. | 7.75M | -0.78% | 1,006,414 | - |
| 553 | SLXN | Silexion Therapeutics Corp | 7.63M | 0.41% | 13,009 | - |
| 554 | GRDX | GridAI Technologies Corp. | 7.61M | 12.97% | 28,976 | - |
| 555 | KPRX | Kiora Pharmaceuticals, Inc. | 7.52M | -2.38% | 4,721 | 20.00K |
| 556 | XTLB | XTL Biopharmaceuticals Ltd. | 7.42M | -3.38% | 5,437 | 451.00K |
| 557 | RNAZ | TransCode Therapeutics, Inc. | 7.38M | 2.55% | 2,399 | - |
| 558 | ACXP | Acurx Pharmaceuticals, Inc. | 7.34M | 2.03% | 42,528 | - |
| 559 | PPBT | Purple Biotech Ltd | 6.95M | -7.26% | 110,387 | - |
| 560 | ADIL | Adial Pharmaceuticals, Inc. | 6.80M | -2.56% | 172,835 | - |
| 561 | BGMS | Bio Green Med Solution, Inc. | 6.74M | 1.85% | 9,210 | 81.00K |
| 562 | LYRA | Lyra Therapeutics, Inc. | 6.68M | 1.12% | 8,903 | 600.00K |
| 563 | TOVX | Theriva Biologics, Inc. | 6.47M | 9.48% | 1,694,016 | - |
| 564 | KALA | KALA BIO, Inc. | 6.19M | -0.33% | 434,147 | - |
| 565 | INAB | IN8bio, Inc. | 6.02M | -5.80% | 10,163,953 | - |
| 566 | PMCB | PharmaCyte Biotech, Inc. | 5.76M | 0.93% | 76,129 | - |
| 567 | APRE | Aprea Therapeutics, Inc. | 5.74M | -0.02% | 30,877 | 488.24K |
| 568 | CYCN | Cyclerion Therapeutics, Inc. | 5.40M | -3.40% | 3,688 | 2.86M |
| 569 | CDIO | Cardio Diagnostics Holdings, Inc. | 5.37M | 4.26% | 5,937 | 15.78K |
| 570 | ENVB | Enveric Biosciences, Inc. | 5.22M | 0.89% | 35,846 | - |
| 571 | REVB | Revelation Biosciences, Inc. | 5.21M | -2.29% | 24,124 | - |
| 572 | SILO | Silo Pharma, Inc. | 5.19M | 1.32% | 18,145 | 72.10K |
| 573 | VIVS | VivoSim Labs, Inc. | 5.03M | - | 9,509 | 140.00K |
| 574 | GLMD | Galmed Pharmaceuticals Ltd. | 4.97M | 2.12% | 17,789 | - |
| 575 | XBIO | Xenetic Biosciences, Inc. | 4.93M | 4.37% | 3,264 | 2.86M |
| 576 | MTNB | Matinas BioPharma Holdings, Inc. | 4.80M | -3.23% | 1,051 | - |
| 577 | GNPX | Genprex, Inc. | 4.80M | -4.61% | 119,479 | - |
| 578 | JAGX | Jaguar Health, Inc. | 4.67M | 0.88% | 89,283 | 11.79M |
| 579 | HCWB | HCW Biologics Inc. | 4.31M | -2.11% | 14,403 | 422.03K |
| 580 | XRTX | XORTX Therapeutics Inc. | 4.30M | 2.78% | 15,317 | - |
| 581 | GOVX | GeoVax Labs, Inc. | 4.29M | -39.82% | 26,316,971 | 3.35M |
| 582 | CMND | Clearmind Medicine Inc. | 4.20M | 7.28% | 49,266 | - |
| 583 | ENSC | Ensysce Biosciences, Inc. | 4.18M | 0.88% | 42,981 | 4.49M |
| 584 | CNSP | CNS Pharmaceuticals, Inc. | 4.15M | 0.22% | 2,406 | - |
| 585 | SLRX | Salarius Pharmaceuticals, Inc. | 4.05M | 2.82% | 77,594 | - |
| 586 | INDP | Indaptus Therapeutics, Inc. | 3.59M | -2.84% | 9,890 | - |
| 587 | OGEN | Oragenics, Inc. | 3.58M | 4.26% | 30,212 | - |
| 588 | ARTL | Artelo Biosciences, Inc. | 3.31M | -3.77% | 20,428 | - |
| 589 | AZTR | Azitra, Inc. | 3.29M | 7.37% | 145,140 | 7.50K |
| 590 | SXTP | 60 Degrees Pharmaceuticals, Inc. | 3.25M | -8.40% | 53,965 | 1.36M |
| 591 | PHGE | BiomX Inc. | 3.07M | 6.91% | 43,311 | - |
| 592 | ONCO | Onconetix, Inc. | 2.82M | -1.63% | 22,545 | 1.22M |
| 593 | CDT | CDT Equity Inc. | 2.69M | -1.79% | 33,522 | - |
| 594 | VRAX | Virax Biolabs Group Limited | 2.62M | 3.60% | 49,162 | 2.99K |
| 595 | SPRC | SciSparc Ltd. | 2.45M | -0.66% | 40,957 | 1.31M |
| 596 | PTIX | Protagenic Therapeutics, Inc. | 2.44M | -2.33% | 25,266 | - |
| 597 | SCNI | Scinai Immunotherapeutics Ltd. | 2.42M | 2.70% | 37,940 | 1.15M |
| 598 | DRMA | Dermata Therapeutics, Inc. | 2.28M | 1.83% | 16,727 | - |
| 599 | BDRX | Biodexa Pharmaceuticals Plc | 2.25M | -12.41% | 297,957 | 104.90K |
| 600 | ADTX | Aditxt, Inc. | 2.06M | -7.94% | 398,185 | 5.95K |
| 601 | PBM | Psyence Biomedical Ltd. | 2.02M | -26.03% | 31,903,266 | - |
| 602 | ELAB | PMGC Holdings Inc. | 1.67M | 2.75% | 61,153 | 285.95K |
| 603 | MLEC | Moolec Science SA | 1.35M | 0.93% | 8,311 | 7.83M |
| 604 | GRI | GRI Bio, Inc. | 1.21M | - | 487,133 | - |